查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1985847

美国医疗被动式低温运输包装市场规模、份额和趋势分析报告：按产品、温度要求、最终用途和细分市场划分，预测期为2026-2033年

U.S. Healthcare Passive Cold Chain Packaging Market Size, Share & Trends Analysis Report By Product, By Temperature Requirement (Cool / Controlled Chilled, Controlled Room Temperature ), By End Use, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

美国医疗被动式低温运输包装市场概述

2025 年美国医疗被动低温运输包装市场价值为 22.2 亿美元，预计到 2033 年将达到 54.5 亿美元，2026 年至 2033 年的复合年增长率为 11.9%。

该行业的主要驱动力是温度敏感型生技药品、疫苗和先进治疗方法的生产和分销不断增加，这些都需要可靠且检验的被动式温度控制解决方案。

此外，由于被动式系统具有成本效益高、操作简便的优点，因此在国内医疗物流领域得到了广泛应用，尤其是在最后一公里配送和直接送达患者方面。

对温度敏感型生物製药和疫苗日益增长的需求是美国医疗被动式低温运输包装行业最重要的成长要素之一。与传统药品不同，单株抗体、细胞和基因疗法以及重组蛋白等生物製药对温度波动极为敏感。即使轻微超出建议温度范围，也会损害产品疗效，因此，可靠的被动式低温运输解决方案对于在储存和运输过程中保护药品品质至关重要。

美国凭藉着强大的药物创新能力和不断增长的先进治疗方法核准，继续引领全球生物製药的研发和商业化进程。这些产品需要透过医院、专科药局、临床试验中心以及日益增加的直接配送管道分发给病患。被动式低温运输包装，例如保温运输容器、相变材料和冰袋，提供了一种扩充性且经济高效的方法，无需像使用全套主动式製冷系统那样增加运作负担，即可确保温度控制。

随着免疫接种计划的扩大、季节性流感疫苗供应链的完善以及应对突发公共卫生事件准备工作的加强，疫苗需求持续增长。疫苗分发涉及巨大的运输量、不稳定的运输时间和复杂的「最后一公里」配送要求。被动式包装因其柔软性、低成本以及在各种气候和运输条件下久经考验的性能而备受青睐。

此外，电子商务在医疗物流领域的广泛应用正成为推动产业发展的主要动力。医疗产品分销管道正从医院和批发商等传统管道扩展到包括数位化订购平台、专科药房网路和直接送达患者等模式。例如，为类风湿性关节炎和多发性硬化症患者提供生物製药的专科药房，越来越多地依赖保温小包裹容器，以确保产品在送货上门过程中保持在规定的2-8°C范围内。这种结构性转变正显着推动市场对检验的被动式低温运输包装解决方案的需求成长。

目录

第一章：调查方法和范围

第二章执行摘要

第三章：美国医疗被动式低温运输包装市场的因素、趋势与范围

  • 市场展望
  • 渗透率和成长预测图
  • 产业价值链分析
    • 原料趋势
    • 製造业趋势
  • 可持续性和可重复利用性的发展趋势
  • 法律规范
  • 市场动态
  • 商业环境分析
    • 波特五力分析
    • PESTEL 分析

第四章：美国医疗被动式低温运输包装市场：依产品类别分類的估价与趋势分析

  • 产品特定波动分析及市场份额（2025 年和 2033 年）
    • 保温容器
    • 保温托盘运输车
    • 凝胶包、干冰系统、相变材料
    • 其他的

第五章：美国医疗被动式低温运输包装市场：依温度要求分類的估算与趋势分析

  • 按温度需求分類的波动和市场份额分析（2025 年和 2033 年）
    • 冷藏/冷冻（2 度C至 8 度C）
    • 冷冻（-20℃ 至 ±5℃）
    • 冷藏/控温冷藏（8°C 至 15°C）
    • 受控室温（CRT）
    • 超低温冷冻（-40 度C至 -60 度C）

第六章：美国医疗被动式低温运输包装市场：依最终用途分類的估算与趋势分析

  • 按最终用途分類的波动和市场份额分析（2025 年和 2033 年）
    • 製药和生物製药公司
    • 医院和医疗机构
    • 诊断和病理检测实验室
    • 研究机构和学术研究机构
    • 临床研究组织（CRO）
    • 血库/血浆采集中心
    • 其他的

第七章 竞争情势

  • 主要企业、近期趋势及其对产业的影响
  • 供应商情况
    • 公司分类
    • 原料供应商和通路伙伴名单
    • 潜在客户名单
  • 竞争环境
    • 企业市场分析
    • 公司热图分析
    • 策略蓝图

第八章：公司列表（概述、财务表现、产品概述）

  • Company Overview
  • 财务业绩
  • 产品基准测试
  • Cold Chain Technologies
  • Peli BioThermal LLC
  • Cryopak
  • CSafe
  • Intelsius
  • TemperPack
  • Coldkeepers, LLC
  • Polar Tech Industries
  • Creative Packaging Co.
  • ThermoSafe
Product Code: GVR-4-68040-848-5

U.S. Healthcare Passive Cold Chain Packaging Market Summary

The U.S. healthcare passive cold chain packaging market size was valued at USD 2.22 billion in 2025 and is projected to reach USD 5.45 billion by 2033, expanding at a CAGR of 11.9% from 2026 to 2033. The industry is primarily driven by the rising production and distribution of temperature-sensitive biologics, vaccines, and advanced therapies, which demand reliable, validated passive temperature control solutions.

Additionally, cost-efficiency and operational simplicity of passive systems make them widely adopted across domestic healthcare logistics, especially for last-mile and direct-to-patient shipments.

The rising demand for temperature-sensitive biologics and vaccines is one of the most significant growth drivers for the U.S. healthcare passive cold chain packaging industry. Unlike conventional pharmaceuticals, biologics such as monoclonal antibodies, cell and gene therapies, and recombinant proteins are highly vulnerable to temperature variations. Even limited exposure outside recommended ranges can compromise product efficacy, making reliable passive cold chain solutions essential for protecting drug quality during storage and distribution.

The U.S. remains a global leader in biologics development and commercialization, supported by strong pharmaceutical innovation and increasing approvals of advanced therapies. These products require distribution across hospitals, specialty pharmacies, clinical trial sites, and increasingly direct-to-patient channels. Passive cold chain packaging, including insulated shippers, phase change materials, and gel packs, offers a scalable and cost-effective approach to ensure temperature control without the operational burden of fully active refrigeration systems.

Vaccines further strengthen this demand, particularly with the expansion of immunization programs, seasonal influenza supply chains, and broader preparedness for public health emergencies. Vaccine distribution involves high shipment volumes, variable transit durations, and complex last-mile delivery requirements. Passive packaging is widely preferred due to its flexibility, lower cost structure, and validated performance across diverse climate and transportation conditions.

Moreover, the increasing adoption of e-commerce in healthcare logistics is becoming a major growth driver for the industry. Healthcare distribution is expanding beyond traditional hospital and wholesaler channels toward digital ordering platforms, specialty pharmacy networks, and direct-to-patient delivery models. For example, specialty pharmacies shipping biologics for rheumatoid arthritis or multiple sclerosis now rely heavily on insulated parcel shippers to ensure products remain within the required 2-8°C range during doorstep delivery. This structural shift is significantly increasing demand for validated passive cold chain packaging solutions.

U.S. Healthcare Passive Cold Chain Packaging Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. healthcare passive cold chain packaging market report based on product, temperature requirement, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
    • Insulated Containers
    • Insulated Pallet Shippers
    • Gel Packs, Dry Ice Systems, PCM
    • Others
  • Temperature Requirement Outlook (Revenue, USD Million, 2021 - 2033)
    • Refrigerated / Chilled (2°C to 8°C)
    • Frozen (-20 °C to +-5 °C)
    • Cool / Controlled Chilled (8 °C to 15 °C)
    • Controlled Room Temperature (CRT)
    • Deep Frozen (-40 °C to -60 °C)
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
    • Pharmaceutical & Biopharmaceutical Companies
    • Hospitals & Healthcare Providers
    • Diagnostic & Pathology Laboratories
    • Research Institutes & Academic Laboratories
    • Clinical Research Organizations (CROs)
    • Blood Banks & Plasma Collection Centers
    • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Research Methodology
    • 1.1.1. Market Segmentation
    • 1.1.2. Market Definition
  • 1.2. Research Scope & Assumptions
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot (USD Million)
  • 2.2. Segmental Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Healthcare Passive Cold Chain Packaging Market Variables, Trends, and Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Raw Material Trends
    • 3.3.2. Manufacturing Trends
  • 3.4. Sustainability and Reusability Trends
  • 3.5. Regulatory Framework
  • 3.6. Market Dynamics
    • 3.6.1. Market Driver Analysis
    • 3.6.2. Market Restraint Analysis
    • 3.6.3. Market Opportunity Analysis
    • 3.6.4. Market Challenge Analysis
  • 3.7. Business Environment Analysis
    • 3.7.1. Porter's Five Forces Analysis
    • 3.7.2. PESTEL Analysis

Chapter 4. U.S. Healthcare Passive Cold Chain Packaging Market: Product Estimates & Trend Analysis

  • 4.1. Key Takeaways
  • 4.2. Products Movement Analysis & Market Share, 2025 & 2033
    • 4.2.1. Insulated Containers
      • 4.2.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.2.2. Insulated Pallet Shippers
      • 4.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.2.3. Gel Packs, Dry Ice Systems, PCM
      • 4.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.2.4. Others
      • 4.2.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Healthcare Passive Cold Chain Packaging Market: Temperature Requirement Estimates & Trend Analysis

  • 5.1. Key Takeaways
  • 5.2. Temperature Requirement Movement Analysis & Market Share, 2025 & 2033
    • 5.2.1. Refrigerated / Chilled (2°C to 8°C)
      • 5.2.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.2.2. Frozen (-20 °C to +-5 °C)
      • 5.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.2.3. Cool / Controlled Chilled (8 °C to 15 °C)
      • 5.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.2.4. Controlled Room Temperature (CRT)
      • 5.2.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.2.5. Deep Frozen (-40 °C to -60 °C)
      • 5.2.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Healthcare Passive Cold Chain Packaging Market: End Use Estimates & Trend Analysis

  • 6.1. Key Takeaways
  • 6.2. End Use Movement Analysis & Market Share, 2025 & 2033
    • 6.2.1. Pharmaceutical & Biopharmaceutical Companies
      • 6.2.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.2.2. Hospitals & Healthcare Providers
      • 6.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.2.3. Diagnostic & Pathology Laboratories
      • 6.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.2.4. Research Institutes & Academic Laboratories
      • 6.2.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.2.5. Clinical Research Organizations (CROs)
      • 6.2.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.2.6. Blood Banks & Plasma Collection Centers
      • 6.2.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.2.7. Others
      • 6.2.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Key Players & Recent Developments & Their Impact on the Industry
  • 7.2. Vendor Landscape
    • 7.2.1. Company Categorization
    • 7.2.2. List of Raw Material Suppliers and Channel Partners
    • 7.2.3. List of Potential Customers
  • 7.3. Competitive Dynamics
    • 7.3.1. Company Market Position Analysis
    • 7.3.2. Company Heat Map Analysis
    • 7.3.3. Strategy Mapping
      • 7.3.3.1. Expansions
      • 7.3.3.2. Mergers & Acquisitions
      • 7.3.3.3. Collaborations
      • 7.3.3.4. New Product Launches
      • 7.3.3.5. Others

Chapter 8. Company Listing (Overview, Financial Performance, Product Overview)

  • 8.1. Company Overview
  • 8.2. Financial Performance
  • 8.3. Product Benchmarking
  • 8.4. Cold Chain Technologies
  • 8.5. Peli BioThermal LLC
  • 8.6. Cryopak
  • 8.7. CSafe
  • 8.8. Intelsius
  • 8.9. TemperPack
  • 8.10. Coldkeepers, LLC
  • 8.11. Polar Tech Industries
  • 8.12. Creative Packaging Co.
  • 8.13. ThermoSafe

List of Tables

  • Table 1 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 2 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, by Insulated Containers, 2021 - 2033 (USD Million)
  • Table 3 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, by Insulated Pallet Shippers , 2021 - 2033 (USD Million)
  • Table 4 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, by Gel Packs, Dry Ice Systems, PCM, 2021 - 2033 (USD Million)
  • Table 5 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, by Others, 2021 - 2033 (USD Million)
  • Table 6 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, by Temperature Requirement, 2021 - 2033 (USD Million)
  • Table 7 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, by Refrigerated / Chilled (2°C to 8°C), 2021 - 2033 (USD Million)
  • Table 8 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, by Frozen (-20 °C to +-5 °C), 2021 - 2033 (USD Million)
  • Table 9 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, by Cool / Controlled Chilled (8 °C to 15 °C), 2021 - 2033 (USD Million)
  • Table 10 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, by Controlled Room Temperature (CRT), 2021 - 2033 (USD Million)
  • Table 11 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, by Deep Frozen (-40 °C to -60 °C), 2021 - 2033 (USD Million)
  • Table 12 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 13 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, in Pharmaceutical & Biopharmaceutical Companies, 2021 - 2033 (USD Million)
  • Table 14 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, in Hospitals & Healthcare Providers, 2021 - 2033 (USD Million)
  • Table 15 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, in Diagnostic & Pathology Laboratories, 2021 - 2033 (USD Million)
  • Table 16 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, in Research Institutes & Academic Laboratories, 2021 - 2033 (USD Million)
  • Table 17 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, in Clinical Research Organizations (CROs), 2021 - 2033 (USD Million)
  • Table 18 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, in Blood Banks & Plasma Collection Centers, 2021 - 2033 (USD Million)
  • Table 19 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, in Others, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Primary Research Process
  • Fig. 4 Market Research Approaches - Bottom-Up Approach
  • Fig. 5 Market Research Approaches - Top-Down Approach
  • Fig. 6 Market Research Approaches - Combined Approach
  • Fig. 7 U.S. Healthcare Passive Cold Chain Packaging Market- Market Snapshot
  • Fig. 8 U.S. Healthcare Passive Cold Chain Packaging Market- Segment Snapshot
  • Fig. 9 U.S. Healthcare Passive Cold Chain Packaging Market- Competitive Landscape Snapshot
  • Fig. 10 U.S. Healthcare Passive Cold Chain Packaging Market: Value Chain Analysis
  • Fig. 11 U.S. Healthcare Passive Cold Chain Packaging Market: Porter's Five Force Analysis
  • Fig. 12 U.S. Healthcare Passive Cold Chain Packaging Market: PESTEL Analysis
  • Fig. 13 U.S. Healthcare Passive Cold Chain Packaging Market: Product Movement Analysis, 2025 & 2033
  • Fig. 14 U.S. Healthcare Passive Cold Chain Packaging Market: Temperature Requirement Movement Analysis, 2025 & 2033
  • Fig. 15 U.S. Healthcare Passive Cold Chain Packaging Market: End Use Movement Analysis, 2025 & 2033
  • Fig. 16 U.S. Healthcare Passive Cold Chain Packaging Market: Company Positioning Analysis
  • Fig. 17 U.S. Healthcare Passive Cold Chain Packaging Market: Strategy Mapping